Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock

Journal of Interferon and Cytokine Research

Volumn 16, Issue 12, 1996, Pages 995-1000

  Yoshizawa, Ken Ichi ^a   Naruto, Masanobu ^a   Ida, Nobutaka ^a  

^a TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBRINOGEN; IMMUNOSUPPRESSIVE ACID PROTEIN; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ANIMALIA; ESCHERICHIA COLI; MURINAE;

EID: 0030452965     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.995     Document Type: Article

References (29)

1. CASTELL, J.V., GÓMEZ-LECHÓN, M.J., DAVID, M., ANDUS, T., GEIGER, T., TRULLENQUE, R., FABRA, R., and HEINRICH, P.C. (1989). Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242, 237-239.
2. IKEBUCHI, K., WONG, G.G., CLARK, S.C., IHLE, J.N., HIRAI, Y., and OGAWA, M. (1987). Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 84, 9035-9039.
3. MURAGUCHI, A., HIRANO, T., TANG, B., MATSUDA, T., HORII, Y., NAKAJIMA, K., and KISHIMOTO, T. (1988). The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167, 332-344.
4. KAWANO, M., HIRANO, T., MATSUDA, T., TAGA, T., HORII, Y., IWATO, K., ASAOKU, H., TANG, B., TANABE, O., TANAKA, H., KURAMOTO, A., and KISHIMOTO, T. (1988). Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332, 83-85.
5. HOUSSIAU, F.A., DEVOGELAER, J.P., VAN DAMME, J., NAGANT DE DEUXCHAISNES, C., and VAN SNICK, J. (1988). Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784-788.
6. WAAGE, A., BRANDTZAEG, P., HALSTENSEN, A., KIERULF, P., and ESPEVIC, T. (1989). The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169, 333-338.
7. KELLY, N.M., and CROSS, A.S. (1992). Interleukin-6 is a better marker of lethality than tumor necrosis factor in endotoxin treated mice. FEMS Micro. Immunol. 89, 317-322.
8. YOSHIMOTO, T., NAKANISHI, K., HIROSE, S., HIROISHI, K., OKAMURA, H., TAKEMOTO, Y., KANAMARU, A., HADA, T., TAMURA, T., KAKISHITA, E., and HIGASHINO, K. (1992). High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J. Immunol. 148, 3596-3603.
9. LIBERT, C., VINK, A., COULIE, P., BROUCKAERT, P., EVERAERDT, B., VAN SNICK, J., and FIERS, W. (1992). Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur. J. Immunol. 22, 2625-2630.
10. STARNES, H.F., PEARCE, M.K., TEWARI, A., YIM, J.H., ZOU, J.-C., and ABRAMS, J.S. (1990). Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145, 4185-4191.
11. BARTON, B.E., and JACKSON, J.V. (1993). Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61, 1496-1499.
12. YOSHIZAWA, K., OKAMOTO, T., MORIYA, K., IZAWA, A., SATOH, Y., NARUTO, M., and IDA, N. (1994). Effects of natural human interleukin-6 on thrombopoiesis and tumor progression in tumor-bearing mice. Cancer Lett. 79, 83-89.
13. IDA, N., SAKURAI, S., HOSAKA, T., HOSOI, K., KUNITOMO, T., SHIMAZU, T., MARUYAMA, T., MATSUURA, Y., and KOHASE, M. (1989). Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis. Biochem. Biophys. Res. Commun. 165, 728-734.
14. IDA, N., SAKURAI, S., HOSAKA, T., HOSOI, K., KUNITOMO, T., MATSUURA, Y., and KOHASE, M. (1990). An enzyme-linked immunosorbent assay for the measurement of human interleukin-6. J. Immunol. Methods 133, 279-284.
15. ESKANDARI, M.K., BOLGOS, G., MILLER, C., NGUYEN, D.T., DEFORCE, L.E., and REMICK, D.G. (1992). Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148, 2724-2730.
16. GOLDBLUM, S.E., WU, K.-M., and JAY, M. (1985). Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59, 1978-1985.
17. REMICK, D.G., STRIETER, R.M., ESKANDARI, M.K., NGUYEN, D.T., GENORD, M.A., RAIFORD, C.L., and KUNKEL, S.L. (1990). Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136, 49-60.
18. GEIGER, T., ANDUS, T., KLAPPROTH, J., HIRANO, T., KISHIMOTO, T., and HEINRICH, P.C. (1988). Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18, 717-721.
19. ECHTENACHER, B., FALK, W., MANNEL, D.N., and KRAMMER, P.H. (1990). Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145, 3762-3766.
20. KURUP, V.P., CHOI, H., RESNICK, A., KALBFLEISCH, J., and FINK, J.N. (1990). Immunopathological response of C57BL/6 and C3H/HeN mice to Aspergillus fumigatus antigens. Int. Arch. Allergy Appl. Immunol. 91, 145-154.
21. ADERKA, D., LE, J., and VILČEK, J. (1989). IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143, 3517-3523.
22. ULICH, T.R., YIN, S., GUO, K., YI, E.S., REMICK, D., and DEL CASTILLO, J. (1991). Intratracheal injection of endotoxin and cytokines: II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol. 138, 1097-1101.
23. 1-antitrypsin mutants against proteolytic enzymes of the kallikreinkinin, complement, and fibrinolytic systems. J. Biol. Chem. 265, 10786-10791.
24. YOSHIKAWA, T., TAKANO, H., TAKAHASHI, S., ICHIKAWA, H., and KONDO, M. (1994). Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ. Shock 42, 53-58.
25. 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J. Clin. Invest. 84, 138-144.
26. ISHIDA, N., SHIBATA, Y., and TAMURA, K. (1982). Serum protein factors against self-defense which are activated in cancer patients. In: Self-Defense Mechanisms, Role of Macrophages. D. Mizuno et al. (eds.) Tokyo: University of Tokyo Press, pp. 239-250.
27. 1-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res. 43, 2889-2896.
28. RYFFEL, B., KAMMÜLLER, M., ROBISON, R., and MYERS, L. (1992). Pathology induced by interleukin-6. Toxicol. Lett. 64, 311-319.
29. RYFFEL, B., CAR, B.D., WOERLY, G., WEBER, M., DIPADOVA, F., KAMMÜLLER, M., KLUG, S., NEUBERT, R., and NEUBERT, D. (1994). Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate - the marmoset. Blood 83, 2093-2102.